Showing results (81-90 of 169) with videos related to
Sort By:
Pageof 17
American Journal of Clinical Pathology|April 20, 2011
The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrowSheren F Younes, Andrew H Beck, Robert S Ohgami, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
A Phase I Clinical Trial Adding OX40 Agonism to In Situ Therapeutic Cancer Vaccination in Patients with Low-Grade B-cell Lymphoma Highlights Challenges in Translation from Mouse to Human StudiesTanaya Shree, Debra Czerwinski, Sarah Haebe, et al.Protein Science : a Publication of the Protein Society|August 10, 2016
Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studiesNanjie Deng, Ashley Hoyte, Yara E Mansour, et al.Proteomics|March 2, 2018
T-Cell Immunopeptidomes Reveal Cell Subtype Surface Markers Derived From Intracellular ProteinsNiclas Olsson, Liora M Schultz, Lichao Zhang, et al.Leukemia & Lymphoma|January 7, 2009
Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphomaJohn M Timmerman, Julie M Vose, Debra K Czerwinski, et al.American Journal of Clinical Pathology|January 15, 2009
The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entitiesDita Gratzinger, Shuchun Zhao, Robert West, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Impaired Immune Health in Survivors of Diffuse Large B-Cell LymphomaTanaya Shree, Qian Li, Sally L Glaser, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 2010
B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progressionJonathan M Irish, June H Myklebust, Ash A Alizadeh, et al.American Journal of Clinical Pathology|July 28, 2010
Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphomaDavid K Durnick, Mark E Law, Matthew J Maurer, et al.Cell Chemical Biology|November 14, 2021
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regressionCaitlyn L Miller, Idit Sagiv-Barfi, Patrick Neuhöfer, et al.Pageof 17